首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Hageman factor-independent fibrinolytic pathway
【2h】

Hageman factor-independent fibrinolytic pathway

机译:Hageman因子非依赖性纤溶途径

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The lysis of clots formed by the addition of thrombin to dilute whole plasma containing 125I-labelled fibrinogen was examined in kinetic assays which assessed clot size and release of radiolabel into the lysate. Neither platelets, immunoglobulin, nor Hageman factor was essential for clot lysis in this system. Clot lysis was normal in plasma from patients genetically deficient in either C2 or C6 but abnormal in the plasma of two patients with acquired C3 deficiency. Plateletdeficient plasma depleted of C3 by cobra venom factor or adsorbed with zymosan did not sustain clot lysis. These findings indicate the existence of a humoral fibrinolytic pathway in whole human plasma dependent upon C3 but independent of Hageman factor.
机译:在动力学测定法中检查了通过添加凝血酶稀释含 125 I标记的纤维蛋白原的全血浆形成的血凝块的溶解度,该实验评估了血凝块的大小和放射性标记释放到裂解液中。血小板,免疫球蛋白或Hageman因子对于该系统中的血块溶解都不是必需的。 C2或C6基因缺乏的患者血浆中的血块溶解正常,但两名获得性C3缺乏的患者血浆中血块溶解异常。缺乏眼镜蛇毒因子或吸附酵母聚糖的C3导致的血小板不足血浆不能维持血块溶解。这些发现表明在整个人血浆中,存在依赖于C3但不依赖Hageman因子的体液纤溶途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号